Anish Suri, President and CSO at Cue Biopharma, Inc. (CUE), sold 800 shares at $20.01 ($16K) on 2020-08-05, disclosed to the SEC on 2020-08-07.
Scheduled sale ($16k) by President and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CUE | SELL | 2021-11-15 | $301K | — | Filing → |
| CUE | SELL | 2021-09-27 | $305K | — | Filing → |
| CUE | SELL | 2020-08-05 | $240K | — | Filing → |